Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In Silico Discovery of 5'-Modified 7-Deoxy-7-ethynyl-4'-thioadenosine as a HASPIN Inhibitor and Its Synergistic Anticancer Effect with the PLK1 Inhibitor. | ACS Cent Sci | 2023 | 37396870 | PubTator, text mining | PubMed |
| A Drosophila model of diabetic neuropathy reveals a role of proteasome activity in the glia. | iScience | 2023 | 37378316 | PubTator, text mining | PubMed |
| The central inflammatory regulator IκBζ: induction, regulation and physiological functions. | Front Immunol | 2023 | 37377955 | PubTator, text mining | PubMed |
| NF-κB in Cell Deaths, Therapeutic Resistance and Nanotherapy of Tumors: Recent Advances. | Pharmaceuticals (Basel) | 2023 | 37375731 | PubTator, text mining | PubMed |
| Molecular Mechanisms for the Vicious Cycle between Insulin Resistance and the Inflammatory Response in Obesity. | Int J Mol Sci | 2023 | 37372966 | PubTator, text mining | PubMed |
| The ST2/IL-33 Pathway in Adult and Paediatric Heart Disease and Transplantation. | Biomedicines | 2023 | 37371771 | PubTator, text mining | PubMed |
| Exosomes: A Promising Strategy for Repair, Regeneration and Treatment of Skin Disorders. | Cells | 2023 | 37371095 | PubTator, text mining | PubMed |
| The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer. | Cancers (Basel) | 2023 | 37370720 | PubTator, text mining | PubMed |
| Revealing the roles of TLR7, a nucleic acid sensor for COVID-19 in pan-cancer. | Biosaf Health | 2023 | 37362864 | PubTator, text mining | PubMed |
| Elucidating the role of ubiquitination and deubiquitination in osteoarthritis progression. | Front Immunol | 2023 | 37359559 | PubTator, text mining | PubMed |
| TLR5 Signaling in the Regulation of Intestinal Mucosal Immunity. | J Inflamm Res | 2023 | 37337514 | PubTator, text mining | PubMed |
| Cathepsins in oral diseases: mechanisms and therapeutic implications. | Front Immunol | 2023 | 37334378 | PubTator, text mining | PubMed |
| Cyclin-dependent kinase 5 negatively regulates antiviral immune response by disrupting myeloid differentiation primary response protein 88 self-association. | Virulence | 2023 | 37332205 | PubTator, text mining | PubMed |
| A novel peptide derived from the mannose binding lectin inhibits LPS-activated TLR4/NF-κB signaling and suppresses ocular inflammation. | Cell Biol Int | 2023 | 37332141 | PubTator, text mining | PubMed |
| The MyD88 inhibitor, ST2825, induces cell cycle arrest and apoptosis by suppressing the activation of the NF‑κB/AKT1/p21 pathway in pancreatic cancer. | Oncol Rep | 2023 | 37326109 | PubTator, text mining | PubMed |
| Induction of Immune Responses and Phosphatidylserine Exposure by TLR9 Activation Results in a Cooperative Antitumor Effect with a Phosphatidylserine-targeting Prodrug. | Int J Biol Sci | 2023 | 37324949 | PubTator, text mining | PubMed |
Identification of a heterozygous pathogenic variant in IRAK4 in an adult patient with pneumococcal sepsis, monoclonal gammopathy of uncertain significance, and idiopathic systemic capillary leak syndrome. | J Allergy Clin Immunol Glob | 2023 | 37304620 | PubTator, text mining | PubMed |
| Interleukin-33: Friend or Foe in Gastrointestinal Tract Cancers? | Cells | 2023 | 37296602 | PubTator, text mining | PubMed |
| Novel agents in relapsed/refractory diffuse large B-cell lymphoma. | Hematol Oncol | 2023 | 37294966 | PubTator, text mining | PubMed |
| Human RELA dominant-negative mutations underlie type I interferonopathy with autoinflammation and autoimmunity. | J Exp Med | 2023 | 37273177 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=19